Fleseriu, M.
~ 100  Ergebnisse:
Personensuche X
?
1

A systematic literature review to evaluate extended dosing ..:

Fleseriu, M ; Zhang, Z ; Hanman, K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708130/.  , 2022
 
?
3

Levoketoconazole improves clinical signs and symptoms and p..:

Geer, EB ; Salvatori, R ; Elenkova, A...
Geer , EB , Salvatori , R , Elenkova , A , Fleseriu , M , Pivonello , R , Witek , P , Feelders , R A , Bex , M , Borresen , SW , Puglisi , S , Biller , BMK , Cohen , F & Pecori Giraldi , F 2021 , ' Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome ' , Pituitary , vol. 24 , no. 1 , pp. 104-115 . https://doi.org/10.1007/s11102-020-01103-6.  , 2021
 
?
5

A Pituitary Society update to acromegaly management guideli..:

Fleseriu, M ; Biller, BMK ; Freda, PU...
Fleseriu , M , Biller , BMK , Freda , PU , Gadelha , MR , Giustina , A , Katznelson , L , Molitch , ME , Samson , SL , Strasburger , CJ , van der Lely , AJ & Melmed , S 2021 , ' A Pituitary Society update to acromegaly management guidelines ' , Pituitary , vol. 24 , no. 1 , pp. 1-13 . https://doi.org/10.1007/s11102-020-01091-7.  , 2021
 
?
7

Levoketoconazole improves clinical signs and symptoms and p..:

Geer E. B ; Salvatori R ; Elenkova A...
info:eu-repo/semantics/altIdentifier/pmid/33216275.  , 2021
 
?
8

Pituitary society expert Delphi consensus: operative workfl..:

Marcus, HJ ; Khan, DZ ; Borg, A...
https://discovery.ucl.ac.uk/id/eprint/10130971/1/Marcus2021_Article_PituitarySocietyExpertDelphiCo.pdf.  , 2021
 
?
9

Consensus on diagnosis and management of Cushing's disease:..:

Fleseriu, M ; Auchus, R ; Bancos, I...
https://eprints.whiterose.ac.uk/180612/5/THELANCETDE-D-21-00487R1_Manuscript%20Clean.pdf.  , 2021
 
?
11

Efficacy and safety of osilodrostat in patients with Cushin..:

Pivonello, R ; Fleseriu, M ; Newell-Price, J...
https://eprints.whiterose.ac.uk/163983/2/LINC3%20primary%20ms_submitted%20draft.pdf.  , 2020
 
?
12

Risk factors and management of pasireotide-associated hyper..:

Gadelha, MR ; Gu, F ; Bronstein, MD...
Gadelha , MR , Gu , F , Bronstein , MD , Brue , TC , Fleseriu , M , Shimon , I , van der Lely , AJ , Ravichandran , S , Kandra , A , Pedroncelli , AM & Colao , AAL 2020 , ' Risk factors and management of pasireotide-associated hyperglycemia in acromegaly ' , Endocrine Connections , vol. 9 , no. 12 , pp. 1178-1190 . https://doi.org/10.1530/ec-20-0361.  , 2020
 
?
13

Use of late-night salivary cortisol to monitor response to ..:

Newell-Price, J ; Pivonello, R ; Tabarin, A...
https://eprints.whiterose.ac.uk/156521/8/%5B1479683X%20-%20European%20Journal%20of%20Endocrinology%5D%20Use%20of%20late-night%20salivary%20cortisol%20to%20monitor%20response%20to%20medical%20treatment%20in%20Cushing%E2%80%99s%20disease.pdf.  , 2020
 
?
14

Significant benefits of AIP testing and clinical screening ..:

Marques, P ; Caimari, F ; Hernández-Ramírez, LC...
https://eprints.whiterose.ac.uk/161800/1/AIP%20mutations%20JCEM.pdf.  , 2020
 
1-15